Itti E - Search Results

1

Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case report.

Van Der Gucht A, Abulizi M, Blanc-Durand P, Aoun-Sebaiti M, Emsen B, Gherardi RK, Verger A, Authier FJ, Itti E. Van Der Gucht A, et al. Among authors: itti e. Medicine (Baltimore). 2017 Sep;96(39):e8134. doi: 10.1097/MD.0000000000008134. Medicine (Baltimore). 2017. PMID: 28953647 Free PMC article.

2

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M. Haioun C, et al. Among authors: itti e. Blood. 2005 Aug 15;106(4):1376-81. doi: 10.1182/blood-2005-01-0272. Epub 2005 Apr 28. Blood. 2005. PMID: 15860666 Free article. Clinical Trial.

3

Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma.

Meignan M, Haioun C, Itti E, Rahmouni A, Reyes F. Meignan M, et al. Among authors: itti e. Clin Lymphoma Myeloma. 2006 Jan;6(4):306-13. doi: 10.3816/clm.2006.n.005. Clin Lymphoma Myeloma. 2006. PMID: 16507208 Review.

4

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, Paone G, Talbot JN, Rahmouni A, Meignan M. Lin C, et al. Among authors: itti e. J Nucl Med. 2007 Oct;48(10):1626-32. doi: 10.2967/jnumed.107.042093. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873129 Free article.

5

Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.

Paone G, Itti E, Haioun C, Gaulard P, Dupuis J, Lin C, Meignan M. Paone G, et al. Among authors: itti e. Eur J Nucl Med Mol Imaging. 2009 May;36(5):745-50. doi: 10.1007/s00259-008-1021-9. Epub 2008 Dec 19. Eur J Nucl Med Mol Imaging. 2009. PMID: 19096842

6

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

Itti E, Lin C, Dupuis J, Paone G, Capacchione D, Rahmouni A, Haioun C, Meignan M. Itti E, et al. J Nucl Med. 2009 Apr;50(4):527-33. doi: 10.2967/jnumed.108.057703. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289424 Free article. Clinical Trial.

7

Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.

Itti E, Juweid ME, Haioun C, Yeddes I, Hamza-Maaloul F, El Bez I, Evangelista E, Lin C, Dupuis J, Meignan M. Itti E, et al. J Nucl Med. 2010 Dec;51(12):1857-62. doi: 10.2967/jnumed.110.080556. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078789 Free article. Clinical Trial.

8

Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF).

Passeri E, Villa C, Couette M, Itti E, Brugieres P, Cesaro P, Gherardi RK, Bachoud-Levi AC, Authier FJ. Passeri E, et al. Among authors: itti e. J Inorg Biochem. 2011 Nov;105(11):1457-63. doi: 10.1016/j.jinorgbio.2011.08.006. Epub 2011 Aug 22. J Inorg Biochem. 2011. PMID: 22099155

9

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Véra P, Tilly H, Siegel BA, Gallamini A, Casasnovas RO, Haioun C. Itti E, et al. Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1312-20. doi: 10.1007/s00259-013-2435-6. Epub 2013 May 7. Eur J Nucl Med Mol Imaging. 2013. PMID: 23649463

10

The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).

Palie O, Michel P, Ménard JF, Rousseau C, Rio E, Bridji B, Benyoucef A, Meyer ME, Jalali K, Bardet S, M'vondo CM, Olivier P, Faure G, Itti E, Diana C, Houzard C, Mornex F, Di Fiore F, Vera P. Palie O, et al. Among authors: itti e. Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1345-55. doi: 10.1007/s00259-013-2450-7. Epub 2013 May 29. Eur J Nucl Med Mol Imaging. 2013. PMID: 23715903 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters